Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Critical Care
Published in:

Open Access 01-12-2024 | Respiratory Medicine | Review

A narrative review on lung injury: mechanisms, biomarkers, and monitoring

Authors: Wenping Fan, Biyu Gui, Xiaolei Zhou, Li Li, Huaiyong Chen

Published in: Critical Care | Issue 1/2024

Login to get access

Abstract

Lung injury is closely associated with the heterogeneity, severity, mortality, and prognosis of various respiratory diseases. Effective monitoring of lung injury is crucial for the optimal management and improved outcomes of patients with lung diseases. This review describes acute and chronic respiratory diseases characterized by significant lung injury and current clinical tools for assessing lung health. Furthermore, we summarized the mechanisms of lung cell death observed in these diseases and highlighted recently identified biomarkers in the plasma indicative of injury to specific cell types and scaffold structure in the lung. Last, we propose an artificial intelligence-driven lung injury monitoring model to assess disease severity, and predict mortality and prognosis, aiming to achieve precision and personalized medicine.
Literature
1.
Force USPST, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Caughey AB, Chelmow D, Coker TR, Davis EM, Donahue KE, et al. Screening for chronic obstructive pulmonary disease: US preventive services task force reaffirmation recommendation statement. JAMA. 2022;327(18):1806–11.CrossRef
2.
Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M, Arabi YM, Baroncelli F, Beitler JR, Bellani G, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med. 2023;49(7):727–59.PubMedCrossRef
3.
Zheng Z, Peng F, Zhou Y. Biomarkers in idiopathic pulmonary fibrosis: current insight and future direction. Chin Med J Pulm Crit Care Med. 2024;2(2):72–9.PubMedCrossRef
4.
Savin IA, Zenkova MA, Sen’kova AV. Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process. Int J Mol Sci. 2023;24(22):16042.PubMedCrossRef
5.
Tiotiu Cepuc A, Steiropoulos P, Novakova S, Nedeva D, Novakova P, Chong-Neto H, Fogelbach GG, Kowal K. Airway remodeling in asthma: mechanisms, diagnosis, treatment, and future directions. Arch Bronconeumol. 2024;S0300–2896(24):00367–1363.
6.
Wang J, Li K, Hao D, Li X, Zhu Y, Yu H, Chen H. Pulmonary fibrosis: pathogenesis and therapeutic strategies. MedComm(2020). 2024;5(10):e744.PubMedCrossRef
7.
Wang Q, Xie Z, Wan N, Yang L, Jin Z, Jin F, Huang Z, Chen M, Wang H, Feng J. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis. Chin Med J. 2023;136(11):1278–90.PubMedCrossRef
8.
Deshpande R, Zou C. Pseudomonas aeruginosa induced cell death in acute lung injury and acute respiratory distress syndrome. Int J Mol Sci. 2020;21(15):5356.PubMedCrossRef
9.
Margaroli C, Horati H, Garratt LW, Giacalone VD, Schofield C, Dittrich AS, Rosenow T, Dobosh BS, Lim HS, Frey DL, et al. Macrophage PD-1 associates with neutrophilia and reduced bacterial killing in early cystic fibrosis airway disease. J Cyst Fibros. 2022;21(6):967–76.PubMedCrossRef
10.
Li K, Zhang Q, Li L, Li S, Yue Q, Li X, Li Y, Wang J, Wang S, Yuan Z, et al. DJ-1 governs airway progenitor cell/eosinophil interactions to promote allergic inflammation. J Allergy Clin Immunol. 2022;150(5):1178–93.PubMedCrossRef
11.
Li K, Li M, Li W, Yu H, Sun X, Zhang Q, Li Y, Li X, Li Y, Abel ED, et al. Airway epithelial regeneration requires autophagy and glucose metabolism. Cell Death Dis. 2019;10(12):875.PubMedCrossRef
12.
Rao W, Wang S, Duleba M, Niroula S, Goller K, Xie J, Mahalingam R, Neupane R, Liew AA, Vincent M, et al. Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis. Cell. 2020;181(4):848–64.PubMedCrossRef
13.
Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Kuttner V, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361(6409):eaao4227.PubMedCrossRef
14.
Tsukui T, Wolters PJ, Sheppard D. Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis. Nature. 2024;631(8021):627–34.PubMedCrossRef
15.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMedCrossRef
16.
Bohadana A, Izbicki G, Kraman SS. Fundamentals of lung auscultation. N Engl J Med. 2014;370(21):2053.PubMed
17.
Allen B, Molokie R, Royston TJ. Early detection of acute chest syndrome through electronic recording and analysis of auscultatory percussion. IEEE J Transl Eng Health Med. 2020;8:4900108.PubMedCrossRef
18.
Romei C, Castellana R, Conti B, Bemi P, Taliani A, Pistelli F, Karwoski RA, Carrozzi L, De Liperi A, Bartholmai B. Quantitative texture-based analysis of pulmonary parenchymal features on chest CT: comparison with densitometric indices and short-term effect of changes in smoking habit. Eur Respir J. 2022;60(4):2102618.PubMedCrossRef
19.
Labaki WW, Xia M, Murray S, Hatt CR, Al-Abcha A, Ferrera MC, Meldrum CA, Keith LA, Galban CJ, Arenberg DA, et al. Quantitative emphysema on low-dose CT imaging of the chest and risk of lung cancer and airflow obstruction: an analysis of the national lung screening trial. Chest. 2021;159(5):1812–20.PubMedCrossRef
20.
Balasubramanian A, Wise RA, Stanojevic S, Miller MR, McCormack MC. FEV(1)Q: a race-neutral approach to assessing lung function. Eur Respir J. 2024;63(4):2301622.PubMedCrossRef
21.
Wei X, Narasimhan H, Zhu B, Sun J. Host recovery from respiratory viral infection. Annu Rev Immunol. 2023;41:277–300.PubMedCrossRef
22.
Wang Y, Hao Q, Florence JM, Jung BG, Kurdowska AK, Samten B, Idell S, Tang H. Influenza virus infection induces ZBP1 expression and necroptosis in mouse lungs. Front Cell Infect Microbiol. 2019;9:286.PubMedCrossRef
23.
Wang M, Chang W, Zhang L, Zhang Y. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19. Int J Biol Sci. 2022;18(15):5827–48.PubMedCrossRef
24.
Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, Shen J, Zhou Y, Shi ZL, Zhou P, et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct Target Ther. 2020;5(1):235.PubMedCrossRef
25.
Baral B, Saini V, Tandon A, Singh S, Rele S, Dixit AK, Parmar HS, Meena AK, Jha HC. SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1. Apoptosis. 2023;28(11–12):1596–617.PubMedCrossRef
26.
Liu Z, Garcia Reino EJ, Harschnitz O, Guo H, Chan YH, Khobrekar NV, Hasek ML, Dobbs K, Rinchai D, Materna M, et al. Encephalitis and poor neuronal death-mediated control of herpes simplex virus in human inherited RIPK3 deficiency. Sci Immunol. 2023;8(82):eade2860.PubMedCrossRef
27.
Huang P, Wang X, Lei M, Ma Y, Chen H, Sun J, Hu Y, Shi J. Metabolomics profiles reveal new insights of herpes simplex virus type 1 infection. Int J Mol Sci. 2023;24(2):1521.PubMedCrossRef
28.
Ufimtseva EG, Eremeeva NI, Umpeleva TV, Vakhrusheva DV, Skornyakov SN. Mycobacterium tuberculosis load in host cells and the antibacterial activity of alveolar macrophages are linked and differentially regulated in various lung lesions of patients with pulmonary tuberculosis. Int J Mol Sci. 2021;22(7):3452.PubMedCrossRef
29.
Song D, Meng J, Cheng J, Fan Z, Chen P, Ruan H, Tu Z, Kang N, Li N, Xu Y, et al. Pseudomonas aeruginosa quorum-sensing metabolite induces host immune cell death through cell surface lipid domain dissolution. Nat Microbiol. 2019;4(1):97–111.PubMedCrossRef
30.
Hardy KS, Tuckey AN, Renema P, Patel M, Al-Mehdi AB, Spadafora D, Schlumpf CA, Barrington RA, Alexeyev MF, Stevens T, et al. ExoU induces lung endothelial cell damage and activates pro-inflammatory caspase-1 during pseudomonas aeruginosa infection. Toxins (Basel). 2022;14(2):152.PubMedCrossRef
31.
Ahn D, Prince A. Participation of necroptosis in the host response to acute bacterial pneumonia. J Innate Immun. 2017;9(3):262–70.PubMedCrossRef
32.
Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–67.PubMedCrossRef
33.
Song C, Shi D, Chang K, Li X, Dong Q, Ma X, Wang X, Guo Z, Liu Y, Wang J. Sodium fluoride activates the extrinsic apoptosis via regulating NOX4/ROS-mediated p53/DR5 signaling pathway in lung cells both in vitro and in vivo. Free Radic Biol Med. 2021;169:137–48.PubMedCrossRef
34.
Tian L, Li N, Li K, Tan Y, Han J, Lin B, Lai W, Liu H, Shi Y, Xi Z, et al. Ambient ozone exposure induces ROS related-mitophagy and pyroptosis via NLRP3 inflammasome activation in rat lung cells. Ecotoxicol Environ Saf. 2022;240: 113663.PubMedCrossRef
35.
Zhao P, Zhu J, Bai L, Ma W, Li F, Zhang C, Zhao L, Wang L, Zhang S. Neutrophil extracellular traps induce pyroptosis of pulmonary microvascular endothelial cells by activating the NLRP3 inflammasome. Clin Exp Immunol. 2024;217(1):89–98.PubMedCrossRef
36.
Yang S, Zhang T, Ge Y, Cheng Y, Yin L, Pu Y, Chen Z, Liang G. Ferritinophagy mediated by oxidative stress-driven mitochondrial damage is involved in the polystyrene nanoparticles-induced ferroptosis of lung injury. ACS Nano. 2023;17(24):24988–5004.PubMedCrossRef
37.
Van Eeckhoutte HP, Donovan C, Kim RY, Conlon TM, Ansari M, Khan H, Jayaraman R, Hansbro NG, Dondelinger Y, Delanghe T, et al. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. Eur Respir J. 2023;61(4):2201506.PubMedCrossRef
38.
Hirata Y, Cai R, Volchuk A, Steinberg BE, Saito Y, Matsuzawa A, Grinstein S, Freeman SA. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33(7):1282–94.PubMedCrossRef
39.
Weindel CG, Martinez EL, Zhao X, Mabry CJ, Bell SL, Vail KJ, Coleman AK, Van Portfliet JJ, Zhao B, Wagner AR, et al. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell. 2022;185(17):3214–31.PubMedCrossRef
40.
Rodrigues D, Machado MR, Alves JV, Fraga-Silva TFC, Martins RB, Campos LCB, Francisco DF, Couto AES, Bonato VLD, Arruda E, et al. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor. Am J Physiol Heart Circ Physiol. 2023;325(2):H252–63.PubMedCrossRef
41.
Ai Y, Meng Y, Yan B, Zhou Q, Wang X. The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death. Mol Cell. 2024;84(1):170–9.PubMedCrossRef
42.
Hao Q, Shetty S, Tucker TA, Idell S, Tang H. Interferon-gamma preferentially promotes necroptosis of lung epithelial cells by upregulating MLKL. Cells. 2022;11(3):563.PubMedCrossRef
43.
Peng W, Chang M, Wu Y, Zhu W, Tong L, Zhang G, Wang Q, Liu J, Zhu X, Cheng T, et al. Lyophilized powder of mesenchymal stem cell supernatant attenuates acute lung injury through the IL-6-p-STAT3-p63-JAG2 pathway. Stem Cell Res Ther. 2021;12(1):216.PubMedCrossRef
44.
Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–79.PubMedCrossRef
45.
Xiong S, Hong Z, Huang LS, Tsukasaki Y, Nepal S, Di A, Zhong M, Wu W, Ye Z, Gao X, et al. IL-1beta suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest. 2023;133(5): e169500.PubMedCrossRef
46.
Melero I, Villalba-Esparza M, Recalde-Zamacona B, Jimenez-Sanchez D, Teijeira A, Argueta A, Garcia-Tobar L, Alvarez-Gigli L, Sainz C, Garcia-Ros D, et al. Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-lymphocyte response in the lungs of patients with fatal COVID-19. Chest. 2022;162(5):1006–16.PubMedCrossRef
47.
Sibila O, Perea L, Albacar N, Moises J, Cruz T, Mendoza N, Solarat B, Lledo G, Espinosa G, Barbera JA, et al. Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge. Respir Res. 2022;23(1):37.PubMedCrossRef
48.
Wang Y, Wang H, Zhang C, Zhang C, Yang H, Gao R, Tong Z. Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2019;23(1):43.PubMedCrossRef
49.
Tiezzi M, Morra S, Seminerio J, Van Muylem A, Godefroid A, Law-Weng-Sam N, Van Praet A, Corbiere V, Orte Cano C, Karimi S, et al. SP-D and CC-16 pneumoprotein’s kinetics and their predictive role during SARS-CoV-2 infection. Front Med. 2021;8: 761299.CrossRef
50.
Rohmann N, Sturmer P, Geisler C, Schlicht K, Hartmann K, Turk K, Hollstein T, Tran F, Rosenstiel P, Franke A, et al. Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection. Front Immunol. 2022;13:1037115.PubMedCrossRef
51.
Lim MJ, Zinter MS, Chen L, Wong KMY, Bhalla A, Gala K, Guglielmo M, Alkhouli M, Huard LL, Hanudel MR, et al. Beyond the alveolar epithelium: plasma soluble receptor for advanced glycation end products is associated with oxygenation impairment, mortality, and extrapulmonary organ failure in children with acute respiratory distress syndrome. Crit Care Med. 2022;50(5):837–47.PubMedCrossRef
52.
Yamaguchi K, Iwamoto H, Mazur W, Miura S, Sakamoto S, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, et al. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis. Respir Res. 2020;21(1):145.PubMedCrossRef
53.
Atzeni IM, Al-Adwi Y, der Doornbos-van Meer B, Roozendaal C, Stel A, van Goor H, Gan CT, Dickinson M, Timens W, Smit AJ, et al. The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis. Front Immunol. 2023;14:1189257.PubMedCrossRef
54.
Shao H, Qin Z, Geng B, Wu J, Zhang L, Zhang Q, Wu Q, Li L, Chen H. Impaired lung regeneration after SARS-CoV-2 infection. Cell Prolif. 2020;53(12): e12927.PubMedCrossRef
55.
Dalgard C, Wang F, Titlestad IL, Kyvik KO, Vestbo J, Sorensen GL. Increased serum SP-D in identification of high-risk smokers at high risk of COPD. Am J Physiol Lung Cell Mol Physiol. 2021;320(6):L1005–10.PubMedCrossRef
56.
Elhai M, Hoffmann-Vold AM, Avouac J, Pezet S, Cauvet A, Leblond A, Fretheim H, Garen T, Kuwana M, Molberg O, et al. Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease. Arthritis Rheumatol. 2019;71(6):972–82.PubMedCrossRef
57.
Byeon SK, Madugundu AK, Garapati K, Ramarajan MG, Saraswat M, Kumar MP, Hughes T, Shah R, Patnaik MM, Chia N, et al. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. Lancet Digit Health. 2022;4(9):e632–45.PubMedCrossRef
58.
59.
Karadeniz H, Avanoglu Guler A, Ozger HS, Yildiz PA, Erbas G, Bozdayi G, Deveci Bulut T, Gulbahar O, Yapar D, Kucuk H, et al. The prognostic value of lung injury and fibrosis markers, KL-6, TGF-beta1, FGF-2 in COVID-19 patients. Biomark Insights. 2022;17:11772719221135444.PubMedCrossRef
60.
Hashimoto K, Besla R, Zamel R, Juvet S, Kim H, Azad S, Waddell TK, Cypel M, Liu M, Keshavjee S. Circulating cell death biomarkers may predict survival in human lung transplantation. Am J Respir Crit Care Med. 2016;194(1):97–105.PubMedCrossRef
61.
Wei X, Su J, Yang K, Wei J, Wan H, Cao X, Tan W, Wang H. Elevations of serum cancer biomarkers correlate with severity of COVID-19. J Med Virol. 2020;92(10):2036–41.PubMedPubMedCentralCrossRef
62.
Molyneaux PL, Fahy WA, Byrne AJ, Braybrooke R, Saunders P, Toshner R, Albers G, Chua F, Renzoni EA, Wells AU, et al. CYFRA 21–1 predicts progression in idiopathic pulmonary fibrosis: a prospective longitudinal analysis of the PROFILE cohort. Am J Respir Crit Care Med. 2022;205(12):1440–8.PubMedPubMedCentralCrossRef
63.
Stock CJW, Hoyles RK, Daccord C, Kokosi M, Visca D, De Lauretis A, Alfieri V, Kouranos V, Margaritopoulos G, George PM, et al. Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression. Respirology. 2021;26(5):461–8.PubMedCrossRef
64.
Zhang X, Jiang M, Yang J. Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19. Int J Infect Dis. 2021;107:232–3.PubMedCrossRef
65.
Takei Y, Yamada M, Saito K, Kameyama Y, Sugiura H, Makiguchi T, Fujino N, Koarai A, Toyama H, Saito K, et al. Increase in circulating ACE-positive endothelial microparticles during acute lung injury. Eur Respir J. 2019;54(4):1801188.PubMedCrossRef
66.
Strulovici-Barel Y, Kaner RJ, Crystal RG. High apoptotic endothelial microparticle levels measured in asthma with elevated IgE and eosinophils. Respir Res. 2023;24(1):180.PubMedCrossRef
67.
Uehara M, Enomoto N, Mikamo M, Oyama Y, Kono M, Fujisawa T, Inui N, Nakamura Y, Suda T. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis. Respir Med. 2016;114:18–26.PubMedCrossRef
68.
Borrmann M, Brandes F, Kirchner B, Klein M, Billaud JN, Reithmair M, Rehm M, Schelling G, Pfaffl MW, Meidert AS. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19. Front Immunol. 2023;14:1129766.PubMedCrossRef
69.
Papakonstantinou E, Bonovolias I, Roth M, Tamm M, Schumann D, Baty F, Louis R, Milenkovic B, Boersma W, Stieltjes B, et al. Serum levels of hyaluronic acid are associated with COPD severity and predict survival. Eur Respir J. 2019;53(3):1801183.PubMedCrossRef
70.
Yu D, Yin G, Lei J, Gong Y, Zheng L, He D, Lei L, Sun L. The correlation between serum levels of laminin, type IV collagen, type III procollagen N-terminal peptide and hyaluronic acid with the progression of post-COVID-19 pulmonary fibrosis. Front Cell Dev Biol. 2024;12:1382244.PubMedCrossRef
71.
Abraham GR, Kuc RE, Althage M, Greasley PJ, Ambery P, Maguire JJ, Wilkinson IB, Hoole SP, Cheriyan J, Davenport AP. Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19. J Mol Cell Cardiol. 2022;167:92–6.PubMedCrossRef
72.
Pulito-Cueto V, Genre F, Lopez-Mejias R, Mora-Cuesta VM, Iturbe-Fernandez D, Portilla V, Sebastian Mora-Gil M, Ocejo-Vinyals JG, Gualillo O, Blanco R, et al. Endothelin-1 as a biomarker of idiopathic pulmonary fibrosis and interstitial lung disease associated with autoimmune diseases. Int J Mol Sci. 2023;24(2):1275.PubMedCrossRef
73.
Birnhuber A, Fliesser E, Gorkiewicz G, Zacharias M, Seeliger B, David S, Welte T, Schmidt J, Olschewski H, Wygrecka M, et al. Between inflammation and thrombosis: endothelial cells in COVID-19. Eur Respir J. 2021;58(3):2100377.PubMedCrossRef
74.
Ronnow SR, Langholm LL, Karsdal MA, Manon-Jensen T, Tal-Singer R, Miller BE, Vestbo J, Leeming DJ, Sand JMB. Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort. Respir Res. 2020;21(1):202.PubMedCrossRef
75.
Liu N, Long H, Sun J, Li H, He Y, Wang Q, Pan K, Tong Y, Wang B, Wu Q, et al. New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression. J Med Virol. 2022;94(7):3112–20.PubMedCrossRef
76.
Pulito-Cueto V, Remuzgo-Martinez S, Genre F, Atienza-Mateo B, Mora-Cuesta VM, Iturbe-Fernandez D, Lera-Gomez L, Mora-Gil MS, Portilla V, Corrales A, et al. E-selectin, ICAM-1, and ET-1 biomarkers address the concern of the challenging diagnosis of interstitial lung disease in patients with autoimmune diseases. Int J Mol Sci. 2023;24(15):12518.PubMedCrossRef
77.
Juneja GK, Castelo M, Yeh CH, Cerroni SE, Hansen BE, Chessum JE, Abraham J, Cani E, Dwivedi DJ, Fraser DD, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: a single-center prospective longitudinal study. J Thromb Haemost. 2021;19(6):1546–57.PubMedCrossRef
78.
Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE Jr, Matthay MA, et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010;299(1):L3-7.PubMedPubMedCentralCrossRef
79.
Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y, Matsumoto H, Matsuura H, Matsubara T, Shimizu K, et al. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A. 2020;117(36):22351–6.PubMedPubMedCentralCrossRef
80.
Li H, Wu Q, Qin Z, Hou X, Zhang L, Guo J, Li Y, Yang F, Zhang Y, Wu Q, et al. Serum levels of laminin and von Willebrand factor in COVID-19 survivors 6 months after discharge. Int J Infect Dis. 2022;115:134–41.PubMedCrossRef
81.
Jandl K, Berg JL, Birnhuber A, Fliesser E, Borek I, Seeliger B, David S, Schmidt JJ, Gorkiewicz G, Zacharias M, et al. Basement membrane product, endostatin, as a link between inflammation, coagulation and vascular permeability in COVID-19 and non-COVID-19 acute respiratory distress syndrome. Front Immunol. 2023;14:1188079.PubMedCrossRef
82.
Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, et al. Serum endostatin is a novel marker for COPD associated with lower lung function, exacerbation and systemic inflammation. Int J Chron Obstruct Pulmon Dis. 2020;15:397–407.PubMedCrossRef
83.
Zinter MS, Delucchi KL, Kong MY, Orwoll BE, Spicer AS, Lim MJ, Alkhouli MF, Ratiu AE, McKenzie AV, McQuillen PS, et al. Early plasma matrix metalloproteinase profiles a novel pathway in pediatric acute respiratory distress syndrome. Am J Respir Crit Care Med. 2019;199(2):181–9.PubMedCrossRef
84.
Mulet A, Tarraso J, Rodriguez-Borja E, Carbonell-Asins JA, Lope-Martinez A, Marti-Martinez A, Murria R, Safont B, Fernandez-Fabrellas E, Ros JA, et al. Biomarkers of fibrosis in patients with COVID-19 1 year after hospital discharge: a prospective cohort study. Am J Respir Cell Mol Biol. 2023;69(3):321–7.PubMedCrossRef
85.
Zingaropoli MA, Latronico T, Pasculli P, Masci GM, Merz R, Ciccone F, Dominelli F, Del Borgo C, Lichtner M, Iafrate F, et al. Tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and pulmonary involvement in COVID-19 pneumonia. Biomolecules. 2023;13(7):1040.PubMedCrossRef
86.
Uysal P, Uzun H. Relationship between circulating serpina3g, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 and -2 with chronic obstructive pulmonary disease severity. Biomolecules. 2019;9(2):62.PubMedCrossRef
87.
Duch P, Diaz-Valdivia N, Ikemori R, Gabasa M, Radisky ES, Arshakyan M, Gea-Sorli S, Mateu-Bosch A, Bragado P, Carrasco JL, et al. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biol. 2022;111:207–25.PubMedCrossRef
88.
Murphy SL, Halvorsen B, Holter JC, Huse C, Tveita A, Troseid M, Hoel H, Kildal AB, Holten AR, Lerum TV, et al. Circulating markers of extracellular matrix remodelling in severe COVID-19 patients. J Intern Med. 2023;294(6):784–97.PubMedCrossRef
89.
90.
Que Y, Hu C, Wan K, Hu P, Wang R, Luo J, Li T, Ping R, Hu Q, Sun Y, et al. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. Int Rev Immunol. 2022;41(2):217–30.PubMedCrossRef
91.
Chen X, Luan M, Liu J, Yao Y, Li X, Wang T, Zhang H, Han Y, Lu X, Chen W, et al. Risk factors in air pollution exposome contributing to higher levels of TNFalpha in COPD patients. Environ Int. 2022;159: 107034.PubMedCrossRef
92.
Ma C, Meng K, Shi S, Zhao T, Chen S, Zhou X, Shu R, Ma M, Tian M, Ding J. Clinical significance of interleukin-6, total bilirubin, CD3 + CD4 + T cells counts in the acute exacerbation of connective tissue disease-associated interstitial lung disease: a cross-sectional study. Eur J Med Res. 2023;28(1):393.PubMedCrossRef
93.
Golan-Gerstl R, Wallach-Dayan SB, Amir G, Breuer R. Epithelial cell apoptosis by fas ligand-positive myofibroblasts in lung fibrosis. Am J Respir Cell Mol Biol. 2007;36(3):270–5.PubMedCrossRef
94.
Saleki K, Shirzad M, Javanian M, Mohammadkhani S, Alijani MH, Miri N, Oladnabi M, Azadmehr A. Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients. Front Immunol. 2022;13: 947401.PubMedCrossRef
95.
Dai L, He J, Chen J, Wang T, Liu L, Shen Y, Chen L, Wen F. The association of elevated circulating endocan levels with lung function decline in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:3699–706.PubMedCrossRef
96.
Galvan-Roman JM, Rodriguez-Garcia SC, Roy-Vallejo E, Marcos-Jimenez A, Sanchez-Alonso S, Fernandez-Diaz C, Alcaraz-Serna A, Mateu-Albero T, Rodriguez-Cortes P, Sanchez-Cerrillo I, et al. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an observational study. J Allergy Clin Immunol. 2021;147(1):72–80.PubMedCrossRef
97.
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–30.PubMedCrossRef
98.
Chen IY, Moriyama M, Chang MF, Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol. 2019;10:50.PubMedCrossRef
99.
Yang ML, Wang CT, Yang SJ, Leu CH, Chen SH, Wu CL, Shiau AL. IL-6 ameliorates acute lung injury in influenza virus infection. Sci Rep. 2017;7:43829.PubMedCrossRef
100.
Moore AR, Pienkos SM, Sinha P, Guan J, O’Kane CM, Levitt JE, Wilson JG, Shankar-Hari M, Matthay MA, Calfee CS, et al. Elevated plasma interleukin-18 identifies high-risk acute respiratory distress syndrome patients not distinguished by prior latent class analyses using traditional inflammatory cytokines: a retrospective analysis of two randomized clinical trials. Crit Care Med. 2023;51(12):e269–74.PubMedCrossRef
101.
Kubysheva N, Boldina M, Eliseeva T, Soodaeva S, Klimanov I, Khaletskaya A, Bayrasheva V, Solovyev V, Villa-Vargas LA, Ramirez-Salinas MA, et al. Relationship of serum levels of IL-17, IL-18, TNF-alpha, and lung function parameters in patients with COPD, asthma-COPD overlap, and bronchial asthma. Mediators Inflamm. 2020;2020:4652898.PubMedCrossRef
102.
Gong R, Luo H, Long G, Xu J, Huang C, Zhou X, Shang Y, Zhang D. Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome. Front Immunol. 2023;14:1158951.PubMedCrossRef
103.
Zhang H, Zhang Q, Liu K, Yuan Z, Xu X, Dong J. Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19. Immun Inflamm Dis. 2024;12(3): e1212.PubMedCrossRef
104.
Huang SJ, Ding ZN, Xiang HX, Fu L, Fei J. Association between serum S100A8/S100A9 heterodimer and pulmonary function in patients with acute exacerbation of chronic obstructive pulmonary disease. Lung. 2020;198(4):645–52.PubMedCrossRef
105.
Shen Y, Yang T, Guo S, Li X, Chen L, Wang T, Wen F. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators Inflamm. 2013;2013: 972347.PubMedCrossRef
106.
Hernandez-Beeftink T, Guillen-Guio B, Rodriguez-Perez H, Marcelino-Rodriguez I, Lorenzo-Salazar JM, Corrales A, Prieto-Gonzalez M, Rodriguez-Perez A, Carriedo D, Blanco J, et al. Whole-blood mitochondrial DNA copies are associated with the prognosis of acute respiratory distress syndrome after sepsis. Front Immunol. 2021;12: 737369.PubMedCrossRef
107.
Faizan MI, Chaudhuri R, Sagar S, Albogami S, Chaudhary N, Azmi I, Akhtar A, Ali SM, Kumar R, Iqbal J, et al. NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles. Cells. 2022;11(19):2969.PubMedCrossRef
108.
Korde A, Haslip M, Pednekar P, Khan A, Chioccioli M, Mehta S, Lopez-Giraldez F, Bermejo S, Rojas M, Dela Cruz C, et al. MicroRNA-1 protects the endothelium in acute lung injury. JCI Insight. 2023;8(18): e164816.PubMedCrossRef
109.
Lu Q, Yu S, Meng X, Shi M, Huang S, Li J, Zhang J, Liang Y, Ji M, Zhao Y, et al. MicroRNAs: important regulatory molecules in acute lung injury/acute respiratory distress syndrome. Int J Mol Sci. 2022;23(10):5545.PubMedCrossRef
110.
Gonzalez-Ramirez J, Leija-Montoya AG, Serafin-Higuera N, Guzman-Martin CA, Amezcua-Guerra LM, Olvera-Sandoval C, Machado-Contreras JR, Ruiz-Hernandez A, Hernandez-Diazcouder A, Estrada-Guzman JD, et al. Increased expression of lncRNA AC000120.7 and SENP3-EIF4A1 in patients with acute respiratory distress syndrome induced by SARS-CoV-2 infection: a pilot study. Microorganisms. 2023;11(9):2342.PubMedCrossRef
111.
Xu F, Hu L, Wang S, Shen Y, Liu H, Wang Y, Zhu L. Microarray profiling of circular RNAs in LPS-induced Beas-2B cells and identification of circ_2979 as a potential biomarker for ARDS. Cell Signal. 2023;103: 110561.PubMedCrossRef
112.
Cappellano G, Raineri D, Rolla R, Giordano M, Puricelli C, Vilardo B, Manfredi M, Cantaluppi V, Sainaghi PP, Castello L, et al. Circulating platelet-derived extracellular vesicles are a hallmark of Sars-+Cov-2 infection. Cells. 2021;10(1):85.PubMedCrossRef
113.
Lin M, Xu F, Sun J, Song J, Shen Y, Lu S, Ding H, Lan L, Chen C, Ma W, et al. Integrative multi-omics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS. Crit Care. 2024;28(1):213.PubMedCrossRef
114.
Lin H, Liu Q, Zhao L, Liu Z, Cui H, Li P, Fan H, Guo L. Circulating pulmonary-originated epithelial biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Int J Mol Sci. 2023;24(7):6090.PubMedCrossRef
115.
Tanaka H, Toya E, Chubachi S, Namkoong H, Asakura T, Azekawa S, Otake S, Nakagawara K, Fukushima T, Watase M, et al. Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity. Respir Investig. 2024;62(6):1132–6.PubMedCrossRef
116.
Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, Tse D, Etemadi M, Ye W, Corrado G, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019;25(6):954–61.PubMedCrossRef
117.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56.PubMedCrossRef
118.
Fainberg HP, Moodley Y, Triguero I, Corte TJ, Sand JMB, Leeming DJ, Karsdal MA, Wells AU, Renzoni E, Mackintosh J, et al. Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation. Lancet Respir Med. 2024;12(9):681–92.PubMedCrossRef
119.
Hartman E, Scott AM, Karlsson C, Mohanty T, Vaara ST, Linder A, Malmstrom L, Malmstrom J. Interpreting biologically informed neural networks for enhanced proteomic biomarker discovery and pathway analysis. Nat Commun. 2023;14(1):5359.PubMedCrossRef
Metadata
Title
A narrative review on lung injury: mechanisms, biomarkers, and monitoring
Authors
Wenping Fan
Biyu Gui
Xiaolei Zhou
Li Li
Huaiyong Chen
Publication date
01-12-2024

Other articles of this Issue 1/2024

Unravelling the complexity of ventilator-associated pneumonia: a systematic methodological literature review of diagnostic criteria and definitions used in clinical research

New definition of AKI: shifting the focus beyond mortality

Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study

How are Long-Covid, Post-Sepsis-Syndrome and Post-Intensive-Care-Syndrome related? A conceptional approach based on the current research literature

Prognostic value of near-infrared spectroscopy regional oxygen saturation and cerebrovascular reactivity index in acute traumatic neural injury: a CAnadian High-Resolution Traumatic Brain Injury (CAHR-TBI) Cohort Study

Neurologic complications in patients receiving aortic versus subclavian versus femoral arterial cannulation for post-cardiotomy extracorporeal life support: results of the PELS observational multicenter study

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar
SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

  • Webinar | 03-12-2024 | 19:00 (CET)

Join us for an insightful session tailored for pulmonologists and healthcaree professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies. 

On-demand version coming soon

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Learn more

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases
Image Credits